256 related articles for article (PubMed ID: 19874546)
1. Effects of lipopolysaccharide on the induction of mixed chimerism in cyclophosphamide-induced tolerance.
Onzuka T; Tomita Y; Shimizu I; Okano S; Yamada H; Yoshikai Y; Tominaga R
Scand J Immunol; 2009 Nov; 70(5):423-30. PubMed ID: 19874546
[TBL] [Abstract][Full Text] [Related]
2. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.
Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H
Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178
[TBL] [Abstract][Full Text] [Related]
3. Antibody-mediated T-cell reduction or increased levels of chimerism overcome resistance to cyclophosphamide-induced tolerance in NKT-deficient mice.
Onzuka T; Tomita Y; Okano S; Shimizu I; Yamada H; Yoshikai Y; Tominaga R
Scand J Immunol; 2010 Aug; 72(2):106-17. PubMed ID: 20618769
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and limitations of cyclophosphamide-induced tolerance against alphaGal antigen.
Shimizu I; Tomita Y; Iwai T; Kajiwara T; Okano S; Sueishi K; Nomoto K; Yasui H
Scand J Immunol; 2005 Sep; 62(3):271-80. PubMed ID: 16179014
[TBL] [Abstract][Full Text] [Related]
5. The immunoregulatory roles of natural killer T cells in cyclophosphamide-induced tolerance.
Iwai T; Tomita Y; Shimizu I; Kajiwara T; Onzuka T; Okano S; Yasunami Y; Yoshikai Y; Nomoto K; Tominaga R
Transplantation; 2007 Dec; 84(12):1686-95. PubMed ID: 18165782
[TBL] [Abstract][Full Text] [Related]
6. Role of the cytokine profiles produced by invariant natural killer T cells in the initial phase of cyclophosphamide-induced tolerance.
Onzuka T; Tomita Y; Shimizu I; Okano S; Yamada H; Yoshikai Y; Tominaga R
Transplantation; 2008 Nov; 86(9):1301-10. PubMed ID: 19005413
[TBL] [Abstract][Full Text] [Related]
7. Application of chimerism-based drug-induced tolerance to rat into mouse xenotransplantation.
Tomita Y; Shimizu I; Iwai T; Zhang QW; Okano S; Kajiwara T; Onzuka T; Tominaga R
Scand J Immunol; 2006 Oct; 64(4):392-7. PubMed ID: 16970680
[TBL] [Abstract][Full Text] [Related]
8. [Study on the improved effect of anti-TCR alpha beta monoclonal antibody on the induction of transplantation tolerance to the allogeneic skin graft in mice and its mechanisms].
Hao J; Liu J; Xie S
Zhonghua Yi Xue Za Zhi; 2001 May; 81(10):593-6. PubMed ID: 11798930
[TBL] [Abstract][Full Text] [Related]
9. Sequential analysis of anti-alpha Gal natural antibody-producing B cells in GalT knockout mice in cyclophosphamide-induced tolerance.
Shimizu I; Tomita Y; Iwai T; Kajiwara T; Okano S; Nomoto K; Tominaga R
Scand J Immunol; 2006 Jun; 63(6):435-43. PubMed ID: 16764697
[TBL] [Abstract][Full Text] [Related]
10. Sequential mechanisms of cyclophosphamide-induced skin allograft tolerance including the intrathymic clonal deletion followed by late breakdown of the clonal deletion.
Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Nomoto K
J Immunol; 1990 Sep; 145(5):1303-10. PubMed ID: 2143514
[TBL] [Abstract][Full Text] [Related]
11. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
[TBL] [Abstract][Full Text] [Related]
12. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
[TBL] [Abstract][Full Text] [Related]
13. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
[TBL] [Abstract][Full Text] [Related]
14. Absent mRNA accumulation of Th1 or Th2 cytokines in heart allografts with chimerism-based drug-induced tolerance.
Tomita Y; Zhang QW; Matsuzaki G; Shimizu I; Iwai T; Okano S; Nomoto K; Yasui H
Surg Today; 2005; 35(5):364-70. PubMed ID: 15864417
[TBL] [Abstract][Full Text] [Related]
15. Tolerance induction through megadose bone marrow transplantation with two-signal blockade.
Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Kwon CH; Joh JW; Kim SJ
J Surg Res; 2006 Jan; 130(1):102-9. PubMed ID: 16183077
[TBL] [Abstract][Full Text] [Related]
16. Role of peripheral hemopoietic chimerism in achieving donor-specific tolerance in adult mice.
Maeda T; Eto M; Nishimura Y; Nomoto K; Kong YY; Nomoto K
J Immunol; 1993 Feb; 150(3):753-62. PubMed ID: 8423338
[TBL] [Abstract][Full Text] [Related]
17. Importance of suppressor T cells in cyclophosphamide-induced tolerance to the non-H-2-encoded alloantigens. Is mixed chimerism really required in maintaining a skin allograft tolerance?
Tomita Y; Mayumi H; Eto M; Nomoto K
J Immunol; 1990 Jan; 144(2):463-73. PubMed ID: 2136891
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow chimerism and tolerance induced by single-dose cyclophosphamide.
Okayama J; Ko S; Kanehiro H; Kanokogi H; Hisanaga M; Ohashi K; Sho M; Nagao M; Ikeda N; Kanamura T; Akashi S; Nakajima Y
J Surg Res; 2004 Jul; 120(1):102-10. PubMed ID: 15172196
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
[TBL] [Abstract][Full Text] [Related]
20. Non-myeloablative mixed chimerism approaches and tolerance, a split decision.
Luo B; Chan WF; Shapiro AM; Anderson CC
Eur J Immunol; 2007 May; 37(5):1233-42. PubMed ID: 17390394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]